Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

SHA:603351 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,725	3,326	3,572	2,930	5,118	2,979
Market Cap Growth	23.54%	-6.86%	21.88%	-42.75%	71.80%	-9.60%
Enterprise Value	3,973	3,601	3,949	3,260	5,210	2,871
Last Close Price	27.50	24.22	25.64	20.80	37.17	21.31
PE Ratio	25.23	22.72	31.83	30.84	50.49	29.66
PS Ratio	2.83	2.57	3.09	2.64	4.91	4.05
PB Ratio	2.11	1.95	2.24	1.98	3.69	2.29
P/TBV Ratio	2.26	2.09	2.40	2.11	3.92	2.44
P/FCF Ratio	25.35	19.53	75.71	-	-	-
P/OCF Ratio	18.22	15.00	29.70	26.89	-	31.93
EV/Sales Ratio	3.02	2.78	3.42	2.94	5.00	3.90
EV/EBITDA Ratio	12.28	13.05	19.72	18.05	32.14	20.17
EV/EBIT Ratio	22.19	21.27	29.88	27.86	42.55	26.59
EV/FCF Ratio	27.04	21.14	83.72	-	-	-
Debt / Equity Ratio	0.35	0.28	0.31	0.29	0.14	0.09
Debt / EBITDA Ratio	1.89	1.69	2.39	2.26	1.21	0.82
Debt / FCF Ratio	4.16	2.83	10.32	-	-	-
Asset Turnover	0.54	0.56	0.52	0.56	0.60	0.48
Inventory Turnover	5.15	5.04	5.02	5.27	5.92	4.47
Quick Ratio	0.93	0.82	0.72	0.48	0.71	1.20
Current Ratio	1.29	1.20	1.08	0.81	1.10	1.63
Return on Equity (ROE)	8.48%	8.80%	7.10%	6.59%	7.46%	7.91%
Return on Assets (ROA)	4.60%	4.54%	3.74%	3.68%	4.40%	4.36%
Return on Invested Capital (ROIC)	7.33%	7.39%	6.37%	5.93%	7.83%	9.34%
Return on Capital Employed (ROCE)	9.50%	9.50%	7.70%	7.50%	8.60%	8.10%
Earnings Yield	3.96%	4.40%	3.14%	3.24%	1.98%	3.37%
FCF Yield	3.94%	5.12%	1.32%	-4.26%	-4.83%	-6.35%
Dividend Yield	1.45%	1.65%	1.17%	1.35%	0.81%	1.41%
Payout Ratio	45.24%	37.88%	47.61%	56.70%	44.64%	46.87%
Buyback Yield / Dilution	0.43%	-0.29%	-1.00%	-0.35%	-2.25%	-1.83%
Total Shareholder Return	1.91%	1.36%	0.17%	1.00%	-1.44%	-0.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.